Trial Details
RecruitingBasic Information
| Clinical ID | c2042 |
|---|---|
| Identifier | ChiCTR2400089738 |
| Trial Title | Evaluation of the safety, tolerability, pharmacokinetic profile and food effects of AC-101 tablets in healthy subjects: a single-center, randomized, double-blind, placebo-controlled, multiple-dose phase I clinical study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease,IBD |
| Interventions | 300 mg:300 mg/cycle;100 mg(BID):AC-101 tablets: 100 mg times/day, Placebo:1 tablet times/day;200 mg(QD):AC-101 tablets: 200 mg time/day; Placebo: 2 tablets x 1 time/day; |
Participant Information
| Sponsor | The Second Affiliated Hospital of Anhui Medical University |
|---|---|
| City | - |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | Interventional study |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |